No Data
No Data
Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why
Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?
Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress
Express News | Taysha Gene Therapies Announces Oral Presentation on Tsha-102 in Rett Syndrome at Upcoming 9TH World Rett Syndrome Congress
Truist Financial Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
No Data
No Data
I Am 102927471 :